Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Prenat Diagn ; 43(10): 1274-1283, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37658742

RESUMO

OBJECTIVE: Prenatal tracheal occlusion (TO) promotes lung growth and is applied clinically in fetuses with congenital diaphragmatic hernia (CDH). Limited data are available regarding the effect of duration versus timepoint of TO. Our objective was to document the impact of TO on lung development in the near-term period in rats with nitrofen-induced CDH. METHOD: Nitrofen was administered on embryonic day (ED)9 and fetal TO was performed on ED18.5, 19, or 20 (term = ED22). Sham-operated and untouched littermates served as controls. Lungs were harvested in 0.5-day steps and only fetuses with a left-sided CDH were included in further analyses. Healthy fetuses provided a reference for normal near-term lung development. RESULTS: Duration of TO in the nitrofen rat model for CDH predicts lung growth in terms of lung-body-weight ratio as well as an increased mRNA level of the proliferation marker Ki67. Longer TO also induced a more complex airway architecture. The timepoint of TO was not predictive of lung growth. CONCLUSION: In the nitrofen rat model of CDH, a longer period of TO leads to enhanced lung growth and more refined airway architecture.


Assuntos
Obstrução das Vias Respiratórias , Hérnias Diafragmáticas Congênitas , Feminino , Gravidez , Animais , Ratos , Éteres Fenílicos/toxicidade , Pulmão , Proliferação de Células
2.
Europace ; 16(8): 1218-25, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24569572

RESUMO

AIMS: Owing to the increasing use of cardiac implantable electronic devices, there is a growing need for safe and effective techniques to manage device-related complications and lead dysfunction. Lead extraction remains a challenging procedure with inherent risks. We present the 30-day and long-term outcomes of lead extractions in the University Hospitals Leuven. METHODS AND RESULTS: We report a retrospective cohort study of 176 patients admitted to the University Hospitals Leuven between January 2005 and December 2011, for the transvenous extraction of 295 leads. Indications for extraction were lead dysfunction and device upgrade in 84 (47.7%), pocket infection in 61 (34.7%), and systemic infection in 31 patients (17.6%). Extraction was successful in 95.5% of patients with complete removal of the leads or only a minor fragment remaining. One fatal peri-procedural complication occurred. Thirty-day mortality was 3.4% (n = 6). Systemic infection was the only significant predictor of 30-day mortality [odds ratio (OR) 29.706; P = 0.029]. A lower level of haemoglobin prior to extraction also tended to be related with a higher mortality, but this was not significant (OR 2.024; P = 0.082). One-year mortality was 8.5% (n = 15). Systemic infection (OR 9.727; P = 0.009), a lower level of haemoglobin (OR 1.597; P = 0.05), and a higher level of ureum (OR 1.021; P = 0.017) prior to extraction were significant predictors of 1-year mortality. Systemic infection was associated with significantly higher 30-day (19%), 1-year (32%), and long-term (39%) mortality rates. CONCLUSION: Lead extraction can be safely and successfully performed in the majority of patients, with limited life-threatening complications. However, lead extraction because of systemic infection is associated with a significantly higher risk of short- and long-term mortality.


Assuntos
Estimulação Cardíaca Artificial , Desfibriladores Implantáveis , Remoção de Dispositivo/mortalidade , Cardioversão Elétrica/instrumentação , Marca-Passo Artificial , Falha de Prótese , Infecções Relacionadas à Prótese/cirurgia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Bélgica , Estimulação Cardíaca Artificial/efeitos adversos , Remoção de Dispositivo/efeitos adversos , Cardioversão Elétrica/efeitos adversos , Feminino , Hospitais Universitários , Humanos , Estimativa de Kaplan-Meier , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Razão de Chances , Desenho de Prótese , Infecções Relacionadas à Prótese/diagnóstico , Infecções Relacionadas à Prótese/etiologia , Infecções Relacionadas à Prótese/mortalidade , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
3.
Prenat Diagn ; 32(1): 39-44, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22052745

RESUMO

OBJECTIVE: Prenatal tracheal occlusion (TO) promotes lung growth and is applied clinically in fetuses with severe congenital diaphragmatic hernia. Limited data are available regarding the effect of duration of TO on lung development. Our objective was to evaluate the effects of long (2 and 2.5 days) versus short (1 day) TO on lung development in rats with nitrofen-induced diaphragmatic hernia. METHOD: Nitrofen was administered on embryonic day (ED) 9 and fetal TO performed either on ED18.5, 19 or 20 (term = 22 days). Sham-operated and untouched littermates served as controls. On ED21, lungs were harvested and only fetuses with a left-sided diaphragmatic defect were included in further analyses. RESULTS: Lung-body-weight ratio incrementally increased with the duration of TO. Increased proliferation following long TO was confirmed by immunohistochemistry and qRT-PCR for the proliferation marker Ki-67. Irrespective of duration, TO induced more complex airway architecture. Medial wall thickness of pulmonary arteries was thinner after long rather than short TO. CONCLUSION: In the nitrofen rat model of congenital diaphragmatic hernia, a longer period of TO leads to enhanced lung growth and less muscularized pulmonary arteries.


Assuntos
Doenças Fetais/cirurgia , Hérnias Diafragmáticas Congênitas , Pulmão/embriologia , Traqueia/cirurgia , Animais , Proliferação de Células/efeitos dos fármacos , Modelos Animais de Doenças , Feminino , Feto/anormalidades , Feto/cirurgia , Idade Gestacional , Herbicidas/toxicidade , Hérnia Diafragmática/induzido quimicamente , Hérnia Diafragmática/patologia , Hérnia Diafragmática/cirurgia , Pulmão/efeitos dos fármacos , Pulmão/patologia , Tamanho do Órgão , Éteres Fenílicos/toxicidade , Gravidez , Ratos , Ratos Wistar , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa